Biodera - Company finances
|
EUR
|
2021
From: 2021-10-28
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 0 | 6,675 | 23,538 | 30,617 | 44,598 |
| Profit before tax | - | - | - | - | - |
| Net profit | 0 | 201 | 3,095 | 3,871 | 2,272 |
| Equity | 2,500 | 2,701 | 5,796 | 9,666 | 12,273 |
| Liabilities | 0 | 0 | 1,916 | 8,087 | 7,886 |
| Non-current assets | 0 | 0 | 0 | 2,500 | 1,667 |
| Current assets | 2,500 | 2,701 | 7,712 | 15,253 | 18,492 |
| Total assets | 2,500 | 2,701 | 7,712 | 17,753 | 20,159 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 2,831 | 5,458 | 6,351 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | +252.6% | +30.1% | +45.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 7.4% | 40.1% | 21.8% | 11.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 7.4% | 53.4% | 40.0% | 18.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 3.0% | 13.1% | 12.6% | 5.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.3 | 0.8 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 2,472 | 7,846 | 11,852 | 22,299 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biodera - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-15 | 2026-03-16 | 0.28 |
| 2026-02-18 | 2026-03-11 | 0.28 |
| 2026-01-21 | 2026-02-16 | 0.28 |
| 2025-12-16 | 2025-12-18 | 268.80 |
| 2025-10-23 | 2025-11-13 | 0.07 |
| 2025-05-04 | 2025-05-13 | 0.33 |
| 2025-04-24 | 2025-04-29 | 0.33 |
| 2025-01-22 | 2025-02-13 | 0.27 |
| 2025-01-16 | 2025-01-19 | 242.21 |
| 2024-10-29 | 2024-11-17 | 0.14 |
| 2024-10-24 | 2024-10-27 | 0.14 |
| 2024-07-17 | 2024-08-15 | 0.20 |
| 2024-07-16 | 2024-07-16 | 242.21 |
| 2024-05-16 | 2024-06-06 | 0.27 |
| 2024-04-23 | 2024-05-13 | 0.27 |
| 2024-01-16 | 2024-01-18 | 224.03 |
| 2023-11-16 | 2023-11-29 | 0.06 |
| 2023-10-17 | 2023-11-13 | 0.06 |
| 2023-09-18 | 2023-10-12 | 0.06 |
| 2023-08-17 | 2023-09-14 | 0.06 |
| 2023-07-26 | 2023-08-15 | 0.06 |
| 2023-07-24 | 2023-07-25 | 0.07 |
| 2023-05-02 | 2023-06-11 | 0.06 |
| 2023-04-27 | 2023-04-28 | 0.06 |
| 2023-04-25 | 2023-04-25 | 0.06 |
| 2023-02-06 | 2023-02-16 | 0.05 |
| 2023-01-20 | 2023-02-03 | 0.05 |
| 2022-11-21 | 2022-12-14 | 0.10 |
| 2022-10-28 | 2022-11-18 | 0.10 |
Biodera - VMI tax arrears
As of 2026-09-14, the amount of overdue STI tax debt of the company Biodera is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-14 | 1.15 |
| 2026-08-25 | 2026-08-25 | 1.16 |
| 2026-08-18 | 2026-08-24 | 0.17 |
| 2026-08-02 | 2026-08-17 | 0.72 |
| 2026-07-20 | 2026-08-01 | 0.85 |
| 2026-05-28 | 2026-06-05 | 0.34 |
| 2026-05-26 | 2026-05-27 | 0.33 |
| 2026-05-19 | 2026-05-25 | 0.34 |
| 2026-05-15 | 2026-05-18 | 35.03 |
| 2026-04-30 | 2026-05-14 | 0.25 |
| 2026-04-28 | 2026-04-29 | 0.24 |
| 2026-04-24 | 2026-04-27 | 0.25 |
| 2026-03-29 | 2026-04-23 | 0.01 |
| 2026-02-28 | 2026-03-02 | 17.78 |
| 2026-02-18 | 2026-02-21 | 33.62 |
| 2025-10-30 | 2025-11-25 | 0.6 |
| 2025-10-15 | 2025-10-29 | 0.31 |
| 2025-09-28 | 2025-10-14 | 0.03 |
| 2025-08-28 | 2025-09-14 | 0.1 |
| 2025-04-28 | 2025-05-24 | 0.28 |
| 2025-03-28 | 2025-04-25 | 0.29 |
| 2024-10-15 | 2024-10-16 | 0.18 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biodera, UAB (code 305925337) is a Private Limited Liability Company operating in retail sale of other new goods n.e.c. In 2025, the company generated revenue of €44.6K, up 45.7% year on year and 89.5% over two years, showing a clear expansion from €23.5K in 2023 to €30.6K in 2024 and then to the current level. Net profit was €2.3K in 2025, down from €3.9K in 2024 and €3.1K in 2023, so profitability softened even as turnover increased. The 2025 profit margin was 5.1%, compared with 12.6% in 2024 and 13.1% in 2023. The balance sheet remained small but strengthened, with total assets rising to €20.2K from €17.8K in 2024 and €7.7K in 2023. Equity reached €12.3K, while liabilities were €7.9K, leaving an equity ratio of 60.9% and debt-to-equity of 0.64. Asset turnover was 2.21x, ROE 18.5% and ROA 11.3%. Revenue per employee was €22.3K and profit per employee €1.1K.